Similar articles

• Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors.

  Rosenfeld MR, Makman MH, Ahn HS, Thal LJ, Mishra RK, Katzman R. Rosenfeld MR, et al. Adv Biochem Psychopharmacol. 1980;23:83-93. Adv Biochem Psychopharmacol. 1980. PMID: 6249092
• Bromocriptine and lisuride stimulate the accumulation of cyclic AMP in intact slices but not in homogenates of rat neostriatum.

  Saiani L, Trabucchi M, Tonon GC, Spano PF. Saiani L, et al. Neurosci Lett. 1979 Sep;14(1):31-6. doi: 10.1016/0304-3940(79)95339-4. Neurosci Lett. 1979. PMID: 231228
• Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine.

  Fuxe K, Fredholm BB, Ogren SO, Agnati LF, Hökfelt T, Gustafsson JA. Fuxe K, et al. Acta Endocrinol Suppl (Copenh). 1978;216:27-56. Acta Endocrinol Suppl (Copenh). 1978. PMID: 347864 Review. No abstract available.
• Ergot alkaloids and cyclic nucleotides in the CNS.

  Trabucchi M, Hofmann M, Montefusco O, Spano PF. Trabucchi M, et al. Pharmacology. 1978;16 Suppl 1:150-55. doi: 10.1159/000136816. Pharmacology. 1978. PMID: 205889 Review.
• Ergot alkaloids inhibit 3H-naloxone binding to opiate receptors in the rat striatum and hippocampus.

  Kosar E, Sumová A, Jakoubek B. Kosar E, et al. Physiol Bohemoslov. 1986;35(4):334-9. Physiol Bohemoslov. 1986. PMID: 3020603